Literature DB >> 17616493

Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.

Dale B Christensen1, Mary Roth, Troy Trygstad, John Byrd.   

Abstract

OBJECTIVE: To assess the feasibility of a pharmacist-based medication therapy management (MTM) service for North Carolina State Health Plan enrollees.
DESIGN: Before/after design with two control groups.
SETTING: Community pharmacies and an ambulatory care clinic in North Carolina serving patients from October 2004 to March 2005. PARTICIPANTS: 67 patients who used a large number of prescription drugs, 10 community/ambulatory care pharmacists, and more than 600 participants from two control groups.
INTERVENTIONS: Pharmacist-conducted MTM reviews for volunteering patients. MAIN OUTCOME MEASURES: Process measures (type and frequency of drug therapy problems detected and services performed), economic measures (number and cost of medications dispensed), and humanistic measures (patient satisfaction with services).
RESULTS: Pharmacists identified an average of 3.6 potential drug therapy problems (PDTPs) per patient at the first visit. The most common PDTP categories were "potential underuse" and "more cost-effective drug available." Pharmacist actions were divided nearly equally between activities that would result in increased and decreased drug use. Pharmacists recommended a drug therapy change in about 50% of patients and contacted the prescriber more than 85% of the time. About 50% of patients with PDTPs had a change in drug therapy. Prescription use during the postintervention period decreased in both the study and control groups but was statistically significant only among the control groups. No significant differences were observed in patient co-payment or insurer prescription costs. Pharmacists provided the following educational services: medication use (90%), disease management (88%), adherence, and self-care (60%). Survey results indicated that patients highly valued the service.
CONCLUSION: A voluntary MTM program targeted at ambulatory patients using a large number of medications reduced the number of PDTPs but did not necessarily result in reductions in prescription drug use or cost. Nearly all patients received some form of medication adherence or disease education associated with problem detection and resolution. Patient satisfaction levels with the service were very high.

Entities:  

Mesh:

Year:  2007        PMID: 17616493     DOI: 10.1331/JAPhA.2007.06111

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  10 in total

1.  Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists.

Authors:  David S Craig
Journal:  P T       Date:  2010-06

Review 2.  A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.

Authors:  Ernieda Hatah; Rhiannon Braund; June Tordoff; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 3.  Application of drug-related problem (DRP) classification systems: a review of the literature.

Authors:  Benjamin J Basger; Rebekah J Moles; Timothy F Chen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

4.  Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.

Authors:  Susanne B Haga; Jivan Moaddeb; Rachel Mills; Deepak Voora
Journal:  Pharmacogenomics       Date:  2017-02-22       Impact factor: 2.533

Review 5.  Challenges to integrating pharmacogenetic testing into medication therapy management.

Authors:  Susanne B Haga; Nancy M Allen LaPointe; Jivan Moaddeb
Journal:  J Manag Care Spec Pharm       Date:  2015-04

Review 6.  The Effectiveness of Interventions to Evaluate and Reduce Healthcare Costs of Potentially Inappropriate Prescriptions among the Older Adults: A Systematic Review.

Authors:  Sara Mucherino; Manuela Casula; Federica Galimberti; Ilaria Guarino; Elena Olmastroni; Elena Tragni; Valentina Orlando; Enrica Menditto
Journal:  Int J Environ Res Public Health       Date:  2022-05-31       Impact factor: 4.614

7.  Pharmacist Intention to Provide Medication Therapy Management Services in Saudi Arabia: A Study Using the Theory of Planned Behaviour.

Authors:  Ahmed M Alshehri; Omar S Alenazi; Salman A Almutairi; Ali Z Alali; Yasser S Almogbel; Rana E Alonazi; Hind A Alkhelaifi; Waleed M Alshehri; Faisal A Alsehli
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

Review 8.  Medication therapy management services: definitions and outcomes.

Authors:  Annette N Pellegrino; Michelle T Martin; Jessica J Tilton; Daniel R Touchette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 9.  Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease.

Authors:  Verughese Jacob; Jeffrey A Reynolds; Sajal K Chattopadhyay; David P Hopkins; Nicole L Therrien; Christopher D Jones; Jeffrey M Durthaler; Kimberly J Rask; Alison E Cuellar; John M Clymer; Thomas E Kottke
Journal:  Am J Prev Med       Date:  2021-12-04       Impact factor: 5.043

10.  Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management.

Authors:  Sharrel L Pinto; Jinender Kumar; Gautam Partha; Robert A Bechtol
Journal:  Clinicoecon Outcomes Res       Date:  2013-04-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.